Nasdaq:US$18.12 (-0.52) | HKEX:HK$28.75 (-0.90) | AIM:£2.93 (-0.03)
Search Result
Previous Article   |   Next Article
Interim Reports | 17 Aug 2022

Interim Report 2022

Contents

Corporate Information
Chairman’s Statement 4
2021 Interim Results & Business Updates 5
Interim 2022 Financial Results 11
Financial Summary 13
Operations Review

Oncology/Immunology
Other Ventures 

16
28
Use of Non-GAAP Financial Measures and Reconciliation 29
Group Capital Resources 31
Other Information 36
Disclosure of Interests 40
Long Term Incentive Plan 47
Corporate Governance 50
Changes in Information of Directors 51
Interim Unaudited Condensed Consolidated Financial Statements 52
References and Abbreviations 78
Information for Shareholders